The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology …
…, E Pentsova, T Cloughesy, FM Iwamoto… - Neuro …, 2017 - academic.oup.com
Background. The Macdonald criteria and the Response Assessment in Neuro-Oncology (RANO)
criteria define radiologic parameters to classify therapeutic outcome among patients …
criteria define radiologic parameters to classify therapeutic outcome among patients …
Primary dural lymphomas: a review
FM Iwamoto, LE Abrey - Neurosurgical focus, 2006 - thejns.org
✓Primary dural lymphoma (PDL) is a rare subtype of primary central nervous system
lymphoma (PCNSL) that arises from the dura mater and differs biologically from other CNS …
lymphoma (PCNSL) that arises from the dura mater and differs biologically from other CNS …
Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a …
…, S Brem, JL Campian, JE Trusheim, FM Iwamoto… - JAMA …, 2023 - jamanetwork.com
… Dr Iwamoto reported receiving grants from Northwest Biotherapeutics and serving on the
steering committee of this trial during the conduct of the study and receiving personal fees from …
steering committee of this trial during the conduct of the study and receiving personal fees from …
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
…, JN Bruce, YM Saenger, P Sims, FM Iwamoto… - Nature medicine, 2019 - nature.com
Immune checkpoint inhibitors have been successful across several tumor types; however,
their efficacy has been uncommon and unpredictable in glioblastomas (GBM), where <10% of …
their efficacy has been uncommon and unpredictable in glioblastomas (GBM), where <10% of …
[HTML][HTML] First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
…, M Salacz, S Taylor, SD D'Andre, FM Iwamoto… - Journal of translational …, 2018 - Springer
Background Standard therapy for glioblastoma includes surgery, radiotherapy, and
temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed …
temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed …
Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas
PH Gutin, FM Iwamoto, K Beal, NA Mohile… - International Journal of …, 2009 - Elsevier
PURPOSE: Preclinical studies suggest that inhibition of vascular endothelial growth factor (VEGF)
improves glioma response to radiotherapy. Bevacizumab, a monoclonal antibody …
improves glioma response to radiotherapy. Bevacizumab, a monoclonal antibody …
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma
L Nayak, FM Iwamoto, A LaCasce… - Blood, The Journal …, 2017 - ashpublications.org
Primary central nervous system (CNS) lymphoma (PCNSL) and primary testicular lymphoma
(PTL) are rare extranodal large B-cell lymphomas with similar genetic signatures. There are …
(PTL) are rare extranodal large B-cell lymphomas with similar genetic signatures. There are …
Scale to predict survival after surgery for recurrent glioblastoma multiforme
…, N Olsen Bailey, TN Kreisl, FM Iwamoto… - Journal of clinical …, 2010 - ascopubs.org
Purpose Despite initial treatment with surgical resection, radiotherapy, and chemotherapy,
glioblastoma multiforme (GBM) virtually always recurs. Surgery is sometimes recommended …
glioblastoma multiforme (GBM) virtually always recurs. Surgery is sometimes recommended …
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
FM Iwamoto, LE Abrey, K Beal, PH Gutin… - Neurology, 2009 - AAN Enterprises
Background: Bevacizumab has recently been approved by the US Food and Drug
Administration for recurrent glioblastoma (GBM). However, patterns of relapse, prognosis, and …
Administration for recurrent glioblastoma (GBM). However, patterns of relapse, prognosis, and …
Primary CNS lymphoma with intraocular involvement: international PCNSL collaborative group report
…, N Laperriere, E Thiel, N Doolittle, FM Iwamoto… - Neurology, 2008 - AAN Enterprises
Objective: To describe the demographics, diagnostic details, therapeutic management, and
outcome in patients with primary CNS lymphoma (PCNSL) with ocular involvement. Methods…
outcome in patients with primary CNS lymphoma (PCNSL) with ocular involvement. Methods…